1. Ward, D.C. New familial cardiac syndrome in children. J. Irish Med. Ass. 1964, 54, 103.

2. Schwartz, P.J.; Priori, S.G.; Napolitano, C. The Long QT Syndrome. In Cardiac Electrophysiology. From Cell to Bedside; Zipes, D.P., Jalife, J., Eds.; WB Saunders Co: Philadelphia, 2000.

3. Moss, A.J.; Zareba, W.; Hall, W.J.; Schwartz, P.J.; Crampton, R.S.; Benhorin, J.; Vincent, G.M.; Locati, E.H.; Priori, S.G.; Napolitano, C.; Medina, A.; Zhang, L.; Robinson, J.L.; Timothy, K.; Towbin, J.A.; Andrews, M.L. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000, 101, 616-623.

4. Schwartz, P.J.; Priori, S.G.; Cerrone, M.; Spazzolini, C.; Odero, A.; Napolitano, C.; Bloise, R.; De Ferrari, G.M.; Klersy, C.; Moss, A.J.; Zareba, W.; Robinson, J.L.; Hall, W.J.; Brink, P.A.; Toivonen, L.; Epstein, A.E.; Li, C.; Hu,

D. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation 2004, 109, 1826-1833.

5. Schott, J.J.; Charpentier, F.; Peltier, S.; Foley, P.; Drouin,

E.; Bouhour, J.B.; Donnelly, P.; Vergnaud, G.; Bachner, L.; Moisan, J.P. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am. J. Hum. Genet. 1995, 57, 1114-1122.

6. Wang, Q.; Curran, M.E.; Splawski, I.; Burn, T.C.; Millholland, J.M.; VanRaay, T.J.; Shen, J.; Timothy, K.W.; Vincent, G.M.; de Jager, T.; Schwartz, P.J.; Toubin, J.A.; Moss, A.J.; Atkinson, D.L.; Landes, G.M.; Connors, T.D.; Keating, M.T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 1996, 12, 17-23.

7. Curran, M.E.; Splawski, I.; Timothy, K.W.; Vincent, G.M.; Green, E.D.; Keating, M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80, 795-803.

8. Wang, Q.; Shen, J.; Splawski, I.; Atkinson, D.; Li, Z.; Robinson, J.L.; Moss, A.J.; Towbin, J.A.; Keating, M.T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80, 805-811.

9. Mohler, P.J.; Schott, J.J.; Gramolini, A.O.; Dilly, K.W.; Guatimosim, S.; duBell, W.H.; Song, L.S.; Haurogne, K.; Kyndt, F.; Ali, M.E.; Rogers, T.B.; Lederer, W.J.; Escande, D.; Le Marec, H.; Bennett, V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421, 634-639.

10. Keating, M.T.; Sanguinetti, M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001, 104, 569580.

11. Neyroud, N.; Tesson, F.; Denjoy, I.; Leibovici, M.; Donger, C.; Barhanin, J.; Faure, S.; Gary, F.; Coumel, P.; Petit, C.; Schwartz, K.; Guicheney, P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat. Genet. 1997, 15, 186-189.

12. Schulze-Bahr, E.; Wang, Q.; Wedekind, H.; Haverkamp, W.; Chen, Q.; Sun, Y.; Rubie, C.; Hordt, M.; Towbin, J.A.; Borggrefe, M.; Assmann, G.; Qu, X.; Somberg, J.C.; Breithardt, G.; Oberti, C.; Funke, H. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat. Genet. 1997, 17, 267-268.

13. Splawski, I.; Tristani-Firouzi, M.; Lehmann, M.H.; Sanguinetti, M.C.; Keating, M.T. Mutations in the HminK gene cause long QT syndrome and suppress 1Ks function. Nat. Genet. 1997, 17, 338-340.

14. Sanguinetti, M.C.; Curran, M.E.; Spector, P.S.; Keating, M.T. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 2208-2212.

15. Abbott, G.W.; Sesti, F.; Splawski, I.; Buck, M.E.; Lehmann, M.H.; Timothy, K.W.; Keating, M.T.; Goldstein, S.A. MiRP1 forms 1K potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97, 175-187.

16. Bennett, P.B.; Yazawa, K.; Makita, N.; George, A.L., Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376, 683-685.

17. Napolitano, C.; Rivolta, I.; Priori, S.G. Cardiac sodium channel diseases. Clin. Chem. Lab. Med. 2003, 41, 439444.

18. Bennett, V.; Baines, A.J. Spectrin and ankyrin-based pathways: Metazoan inventions for integrating cells into tissues. Physiol. Rev. 2001, 81, 1353-1392.

19. Moss, A.J.; Zareba, W.; Benhorin, J.; Locati, E.H.; Hall, W.J.; Robinson, J.L.; Schwartz, P.J.; Towbin, J.A.; Vincent, G.M.; Lehmann, M.H. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995, 92, 2929 -2934.

20. Zhang, L.; Timothy, K.W.; Vincent, G.M.; Lehmann, M.H.; Fox, J.; Giuli, L.C.; Shen, J.; Splawski, I.; Priori, S.G.; Compton, S.J.; Yanowitz, F.; Benhorin, J.; Moss, A.J.; Schwartz, P.J.; Robinson, J.L.; Wang, Q.; Zareba, W.; Keating, M.T.; Towbin, J.A.; Napolitano, C.; Medina, A. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000, 102, 28492855.

21. Schwartz, P.J.; Priori, S.G.; Spazzolini, C.; Moss, A.J.; Vincent, G.M.; Napolitano, C.; Denjoy, I.; Guicheney, P.; Breithardt, G.; Keating, M.T.; Towbin, J.A.; Beggs, A.H.; Brink, P.; Wilde, A.A.; Toivonen, L.; Zareba, W.; Robinson, J.L.; Timothy, K.W.; Corfield, V.; Wattanasirichaigoon, D.; Corbett, C.; Haverkamp, W.;

Schulze-Bahr, E.; Lehmann, M.H.; Schwartz, K.; Coumel, P.; Bloise, R. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103, 89-95.

22. Moss, A.J.; Robinson, J.L.; Gessman, L.; Gillespie, R.; Zareba, W.; Schwartz, P.J.; Vincent, G.M.; Benhorin, J.; Heilbron, E.L.; Towbin, J.A.; Priori, S.G.; Napolitano, C.; Zhang, L.; Medina, A.; Andrews, M.L.; Timothy, K. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am. J. Cardiol. 1999, 84, 876-879.

23. Ackerman, M.J.; Tester, D.J.; Porter, C.J. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin. Proc. 1999, 74, 1088-1094.

24. Zareba, W.; Moss, A.J.; Schwartz, P.J.; Vincent, G.M.; Robinson, J.L.; Priori, S.G.; Benhorin, J.; Locati, E.H.; Towbin, J.A.; Keating, M.T.; Lehmann, M.H.; Hall, W.J. Influence of genotype on the clinical course of the long-QT syndrome. International long-QT syndrome registry research group. N. Engl. J. Med. 1998, 339, 960-965.

25. Priori, S.G.; Schwartz, P.J.; Napolitano, C.; Bloise, R.; Ronchetti, E.; Grillo, M.; Vicentini, A.; Spazzolini, C.; Nastoli, J.; Bottelli, G.; Folli, R.; Cappelletti, D. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 2003, 348, 1866-1874.

26. Moss, A.J.; Zareba, W.; Kaufman, E.S.; Gartman, E.; Peterson, D.R.; Benhorin, J.; Towbin, J.A.; Keating, M.T.; Priori, S.G.; Schwartz, P.J.; Vincent, G.M.; Robinson, J.L.; Andrews, M.L.; Feng, C.; Hall, W.J.; Medina, A.; Zhang, L.; Wang, Z. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002, 19 (105), 794-799.

27. Vincent, G.M.; Timothy, K.W.; Leppert, M.; Keating, M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N. Engl. J. Med. 1992, 327, 846-852.

28. Priori, S.G.; Napolitano, C.; Schwartz, P.J. Low penetrance in the long-QT syndrome: Clinical impact. Circulation 1999, 99, 529-533.

29. Viswanathan, P.C.; Benson, D.W.; Balser, J.R. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J. Clin. Invest. 2003, 111, 341346.

30. Napolitano, C.; Schwartz, P.J.; Brown, A.M.; Ronchetti, E.; Bianchi, L.; Pinnavaia, A.; Acquaro, G.; Priori, S.G. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J. Cardiovasc. Electrophysiol. 2000, 11, 691-696.

Was this article helpful?

0 0

Post a comment